Loading...
Serologic Status and Toxic Effects of the SARS-CoV-2 BNT162b2 Vaccine in Patients Undergoing Treatment for Cancer
IMPORTANCE: The efficacy and safety profile of SARS-CoV-2 vaccines have been acquired from phase 3 studies; however, patients with cancer were not represented in these trials. Owing to the recommendation to prioritize high-risk populations for vaccination, further data are warranted. OBJECTIVE: To e...
Na minha lista:
| Udgivet i: | JAMA Oncol |
|---|---|
| Main Authors: | , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Medical Association
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8267843/ https://ncbi.nlm.nih.gov/pubmed/34236381 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2021.2675 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|